MethylGene Inc MYLGF

results

[noGnoG8]

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
 

Estimated Enrollment:	60
Study Start Date:	June 2008
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies

Estimated Enrollment:	60
Study Start Date:	April 2008
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

and the fda gave credibilty to  MGCD0103

[Everswan]

https://www.medicalnewstoday.com/articles/171355.php Market has already price in the full awesome pathetic PI results for MGD265. Now we get the final tally. So what? Should market be surprised --- opportunity to escape this sinking boat. Nothing more.